Dermatomyositis and polymyositis (myositis): vizsgálatok itt: Franciaország
31 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 1. fázisTaking peoplePhase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)
- Where
- Montpellier Cedex 5, Paris
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- Chugai Pharmaceutical Co. Ltd.
See details and how to join2024-511346-39-00 - 3. fázisNot yet taking people in FranciaországA Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies
- Where
- Angers, Bordeaux, Caen, Lyon, Paris, Strasbourg, Toulouse
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07789015 · EU 2026-526365-24-00 - 1. fázisTaking peopleA Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Where
- Bordeaux, Montpellier, Nancy, Paris, Strasbourg Cedex 2, Toulouse Cedex 9
- Életkor
- 18 év to 70 év
- People
- 72 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06916806 · EU 2024-519015-34-00 - 3. fázisCsak meghívásosA Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
- Where
- Lyon Cedex 03, Paris, Rouen Cedex, Strasbourg Cedex
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- argenx
See details and how to joinNCT05979441 · EU 2022-502851-79-00 - 1. fázisNot yet taking people in FranciaországA Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
- Where
- Montpellier, Paris
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07873931 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared with Placebo Added to Standard of Care in Adult Participants with Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Where
- Angers, Brest Cedex 2, Le Mans Cedex 9, Lille Cedex, Lyon Cedex 03, Paris, Reims Cedex, Rouen Cedex, Strasbourg Cedex 2, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- AstraZeneca AB
See details and how to join2023-504022-19-01 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Where
- Angers, Brest, Le Mans, Lille, Lyon, Paris, Reims, Rouen, Strasbourg, Toulouse
- Életkor
- 18 év to 75 év
- People
- 240 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06455449 - 2. fázisTaking peopleSubcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study
- Where
- Bordeaux, Bron, Le Kremlin-Bicetre, Limoges, Paris, Paris Cedex 10, Paris Cedex 13, Rennes, Rouen Cedex, Toulouse, Toulouse Cedex 9
- Életkor
- 6 hónap to 64 év
- People
- 40
- Run by
- University Hospital, Limoges
See details and how to joinNCT03582800 · EU 2024-511620-13-00 - 3. fázisTaking peopleA Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- Where
- Lyon, Paris, Reims Cedex, Strasbourg Cedex
- Életkor
- 18 év and over
- People
- 318 worldwide
- Run by
- Pfizer
See details and how to joinNCT05895786 · EU 2022-502739-20-00 - 1. fázisNot yet taking people in FranciaországStudy Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases
- Where
- Villejuif
- Életkor
- 18 év to 75 év
- People
- 6
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07544225 - 1. fázisTaking peopleA Phase 1 Study of the Safety and Preliminary Efficacy of CTX112 in Adult Subjects With Refractory Autoimmune Disease.
- Where
- Clermont-Ferrand, Créteil, Grenoble Cedex 9, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 51 worldwide
- Run by
- CRISPR Therapeutics AG
See details and how to join2024-518528-54-00 - 2. fázisTaking peopleAlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Where
- Marseille, Montpellier, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- Artiva Biotherapeutics, Inc.
See details and how to joinNCT06991114 · EU 2025-520461-41-00 - 1. fázisTaking peoplePhase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Where
- Montpellier Cedex 5, Paris Cedex 13
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00 - 1. fázisCsak meghívásosPhase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
- Where
- Montpellier, Paris
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06723106 - 1. fázisTaking peopleA Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Where
- Lille Cedex, Strasbourg Cedex 2
- Életkor
- 18 év and over
- People
- 125 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00 - No phaseTaking peopleAdult Autoimmune Myopathies (MAIA)
- Where
- Brest
- Életkor
- 18 év and over
- People
- 60
- Run by
- University Hospital, Brest
See details and how to joinNCT04792931 - 1. fázisTaking peopleA Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
- Where
- Bordeaux, Toulouse Cedex 9
- Életkor
- 18 év to 70 év
- People
- 44 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07371468 · EU 2025-522932-15-00 - No phaseTaking peopleIdentification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
- Where
- Paris
- Életkor
- 18 év and over
- People
- 830
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06599411 - No phaseTaking peopleEACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
- Where
- Paris
- Életkor
- 18 év and over
- People
- 5000
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07077304 - 3. fázisTaking peopleBaricitinib in Patients With Relapsing or naïve Dermatomyositis
- Where
- Amiens, Bordeaux, Brest, Clermont-Ferrand, Clermont Ferrand Cedex 1, Creteil, Dijon, Lille, Lyon Cedex 03, Marseille, Montpellier Cedex 5, Nantes, Paris, Paris Cedex 13, Pringy Cedex, Reims Cedex, Strasbourg Cedex 2
- Életkor
- 18 év to 64 év
- People
- 62
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT04972760 · EU 2024-511899-32-00 - 2. fázisTaking peopleRuxolitinib Treatment in Inclusion Body Myositis
- Where
- Angers, Bayonne, Besançon, Bordeaux, Brest, Bron, Caen, Créteil, Garches, Lille, Limoges, Marseille, Montpellier, Nancy, Nantes, Nice, Paris, Reims, Saint-Etienne, Strasbourg, Toulouse
- Életkor
- 45 év and over
- People
- 80
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06536166 - 1. fázisTaking peopleA Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Where
- Paris
- Életkor
- 12 év to 70 év
- People
- 244 worldwide
- Run by
- Fate Therapeutics
See details and how to joinNCT06308978 - No phaseNot yet taking people in FranciaországMuscle Imaging Project Using ANatomopathology and Full Field Optical Coherence Tomography
- Where
- Macon
- Életkor
- 18 év and over
- People
- 20
- Run by
- Centre Hospitalier de Mâcon
See details and how to joinNCT07552220 - No phaseTaking peopleClinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
- Where
- Toulouse
- Életkor
- 6 év to 99 év
- People
- 3000
- Run by
- University Hospital, Toulouse
See details and how to joinNCT05251415 - No phaseTaking peopleClinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
- Where
- Toulouse
- Életkor
- 6 év to 99 év
- People
- 800
- Run by
- University Hospital, Toulouse
See details and how to joinNCT06387654